Not applicableStudy completedNCT07489183
What this trial is testing
A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older
Who this might be right for
Hypercholesterolemia
Dong Wha Pharmaceutical Co. Ltd. 641